Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro

Journal of Virological Methods

Volumn 58, Issue 1-2, 1996, Pages 167-173

  Herbein, Georges ^a,b   Illei, Peter ^a   Montaner, Luis J ^a   James, William ^a   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Formaldehyde; HIV, propiolactone; Indicator cells; p24; Residual infectivity

Indexed keywords

FORMALDEHYDE; GAG PROTEIN; PROPIOLACTONE;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKOCYTE CULTURE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; VIRUS CULTURE; VIRUS INACTIVATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030049410     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02007-1     Document Type: Article

References (17)

1. Aloiso, C.H. and Nicholson, J.K.A. (1990) Recovery of infectious HIV from cells treated with 1% paraformaldehyde. J. Immunol. Methods 128, 281-285.
2. Aranda-Angaldo, A., Viza, D. and Busnel, R.G. (1992) Chemical inactivation of human immunodeficiency virus in vitro. J. Virol. Methods 37, 71-82.
3. Ball, M.J. and Bolton, F.G. (1985) Effects of inactivating HTLV-III on laboratory tests. Lancet ii, 99.
4. Ball, M.J., Spriggs, V., Sutton, P.M. and Chapel, H. (1986) Effects of β propiolactone an inhibitor of HTLVIII/ LAV activity on immunological analyses. J. Immunol. Methods 95, 113-116.
5. Collin, M., Montaner, L.J., Herbein, G. and Gordon, S. (1995) HIV infection of macrophages. In: J. Karn (Ed.), HIV: A Practical Approach. Vol. 1. IRL Press, Oxford, pp. 63-75.
6. Damery, B. and Cremieux, A. (1989) Virucidal activity against herpes and vaccinia virus of eight antiseptic formulations. Int. J. Pharm. 49, 205-208.
7. Gendelman, H.E., Orenstein, J.M., Baca, L.M., Weister, B., Berger, H., Kalter, D.C. and Meltzer, M.S. (1989) The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3, 475-495.
8. Gendelman, H.E., Orenstein, J.M., Martin, M.A., Ferrua, C., Mitra, R., Phipps, T., Wahl, L.A., Clinfford Lane, H., Fauci, A.S., Burke, D.S., Skillman, D. and Meltzer, M.S. (1988) Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167, 1428-1441.
9. Hanson, P.J.V., Gor, D., Jeffries, D.J. and Collins, J.V. (1989) Chemical inactivation of HIV on surfaces. Br. Med. J. 298, 862-864.
10. Herbein, G., Keshav, S., Collin, M., Montaner, L.J. and Gordon, S. (1994) HIV-1 induces tumor necrosis factor and Interleukin-1 gene expression in primary human macrophages independent of productive infection. Clin. Exp. Immunol. 95, 442-449.
11. Lifson, J.D., Sasaki, D.T. and Engelman, E.G. (1986) Utility of formaldehyde fixation for flow cytometry and inactivation of AIDS associated retrovirus. J. Immunol. Methods 86, 143-149.
12. de Madrid, A. and Porterfield, J. (1969) A Simple Micro-culture Method for the Study of Group B Arboviruses. Bull. WHO. 40, 113-121.
13. Martin, L.S., McDougal, J.S. and Loskoski, S.L. (1985) Disinfection and inactivation of the human T lymphotropic virus type III lymphadenopathy-associated virus. J. Infect. Dis. 152, 400-403.
14. Resnick, L., Veren, K., Salahuddin, S.Z., Tondreau, S. and Markham, P.D. (1986) Stability and inactivation of HTLV-III LAV under clinical and laboratory environments. J. Am. Med. Assoc. 255, 1887-1891.
15. Schuitemaker, H., Koot, M., Koostra, N.A., Derkson, M.W., De Goede, R.Y., Van Steenwijk, R.P., Lange, J.M.A., Schattenkerk, J.K.M.E., Miedema, F. and Tersmette, M. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-tropic virus populations. J. Virol. 66, 1354-1360.
16. Simon, J.H.M. Somoza, C., Schockmel, G., Collin, M., Williams, A.F. and James, W. (1993) A rat CD4 mutant containing the gp120-binding site mediates HIV-1 infection. J. Exp. Med. 177, 949-954.
17. Spire, B., Barre-Sinoussi, F., Montagnier, E. and Chermann, J.C. (1984) Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet ii, 899-901.